Just a moment…



Source link

Leave a Reply

Your email address will not be published. Required fields are marked *

Explore More

Just a moment…

Just a moment… Enable JavaScript and cookies to continue This request seems a bit unusual, so we need to confirm that you’re human. Please press and hold the button until

Researchers discover new target for treating heart failure: Protein kinase N

Protein kinase N (PKN) 1 and PKN2 are expressed in cardiac fibroblasts. Credit: Nature Communications (2024). DOI: 10.1038/s41467-024-52068-0, https://www.nature.com/articles/s41467-024-52068-0 As society ages, the number of patients with heart failure is

SGLT2 inhibitor empagliflozin is shown to be safe and effective for treating patients who have suffered a heart attack

Credit: Pixabay/CC0 Public Domain The SGLT2 inhibitor empagliflozin confers kidney-protective benefits and can therefore be given safely and effectively to patients when they are hospitalized for acute myocardial infarction (MI),